DM0000: The mark consists of three lines of stylized wording. The first line is "NIPD GENETICS" in gray in stylized form. The second line is "PRESENTIA" in stylized form, where "PRE" is in yellow, and "SENTIA" is in gray. The third line is "HEREDITARY CANCER" in yellow.
CC0000: The color(s) yellow and grey is/are claimed as a feature of the mark.
GS0011: Kits and reagents for genetic testing for medical and scientific research purposes in the field of cancer detection; kits and reagents for cancer testing for medical and scientific research purposes; nucleic acid based kits and reagents for testing cancer diseases for medical and scientific research purposes
TR0010: The English translation of "PRESENTIA" in the mark is "TO SENSE".
GS0441: Medical analysis services for the diagnosis and prognosis of cancer; medical genetic testing services for diagnosis, prevention and treatment of cancer; medical testing of blood for diagnosis of cancer; genetic testing and genetic counseling in the field of cancer detection; medical and health services relating to DNA and genetics testing; RNA and DNA analysis for cancer diagnosis and prognosis
D10000: "NIPD GENETICS" AND "HEREDITARY CANCER"
GS0421: Medical laboratory services for testing of cancer and cancer prevention; design and development of medical diagnostic tests and products; medical and scientific research in the field of genetic testing; providing medical and scientific research information in the field of genetic testing; genetic testing for scientific research and analysis purposes in the field of cancer detection; genetic engineering services, namely, scientific research in the field of genetic engineering; scientific, laboratory, clinical, medical, and technological research and analysis services in the fields of nucleic acid analysis, cancer testing, and genetics; scientific research for medical purposes in the field of cancerous diseases
Case File Event Statements
6/14/2023 - a year ago
35 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA